Silvant Capital Management LLC Sells 57,116 Shares of UnitedHealth Group Incorporated $UNH

Silvant Capital Management LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 93.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,326 shares of the healthcare conglomerate’s stock after selling 57,116 shares during the period. Silvant Capital Management LLC’s holdings in UnitedHealth Group were worth $1,350,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. HHM Wealth Advisors LLC raised its holdings in UnitedHealth Group by 0.9% during the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock worth $1,544,000 after acquiring an additional 26 shares in the last quarter. Hemington Wealth Management raised its stake in shares of UnitedHealth Group by 2.5% during the 1st quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock worth $604,000 after purchasing an additional 28 shares in the last quarter. Tlwm grew its stake in shares of UnitedHealth Group by 1.0% in the first quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock valued at $1,433,000 after buying an additional 28 shares in the last quarter. MGO One Seven LLC raised its position in UnitedHealth Group by 0.3% during the first quarter. MGO One Seven LLC now owns 8,781 shares of the healthcare conglomerate’s stock worth $4,599,000 after acquiring an additional 30 shares in the last quarter. Finally, Endowment Wealth Management Inc. grew its position in shares of UnitedHealth Group by 5.0% in the 1st quarter. Endowment Wealth Management Inc. now owns 650 shares of the healthcare conglomerate’s stock valued at $341,000 after acquiring an additional 31 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 1.1%

Shares of NYSE UNH opened at $329.78 on Friday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $622.83. The firm has a market capitalization of $298.73 billion, a PE ratio of 17.21, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The firm has a fifty day simple moving average of $343.51 and a two-hundred day simple moving average of $315.21. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business’s revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the firm posted $7.15 EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on UNH shares. Mizuho raised their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Sanford C. Bernstein raised their price objective on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Truist Financial lifted their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Finally, Royal Bank Of Canada raised their target price on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Eighteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.